Agilent at aacr 2024: empowering breakthroughs in cancer research and diagnostics

Santa clara, calif.--(business wire)--agilent technologies inc. (nyse: a), a global leader in life sciences and diagnostics, announced today its participation in the american association for cancer research annual meeting (aacr). at the meeting, which will take place from april 5 to 10, 2024, in san diego, ca, agilent will highlight new cell analysis, genomics, digital pathology, and companion diagnostics solutions. featured products and solutions that play a crucial role in advancing cancer re.
A Ratings Summary
A Quant Ranking